Zobrazeno 1 - 10
of 47
pro vyhledávání: '"L, Haazen"'
Autor:
Ralph Mösges, Elena-Manja Kasche, Mohamed H. Shamji, Sabine Pirotton, Stephen R. Durham, Thierry Legon, Esther Raskopf, Anatoli Astvatsatourov, J Singh, G Zadoyan, Kija Shah-Hosseini, L. Sohlich, L. Haazen
Publikováno v:
Allergy
Background A novel subcutaneous allergen immunotherapy formulation (gpASIT+™) containing Lolium perenne peptides (LPP) and having a short up-dosing phase has been developed to treat grass pollen–induced seasonal allergic rhinoconjunctivitis. We i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fad44527a02c5b0e29be313ef4b521b3
https://doi.org/10.1111/all.13358
https://doi.org/10.1111/all.13358
Autor:
Francis Corazza, Esther Raskopf, A. F. Koch, J Singh, Ralph Mösges, Anatoli Astvatsatourov, Mohamed H. Shamji, B. Hauswald, Silke Allekotte, Stephen R. Durham, Y. Yarin, Thierry Legon, Sabine Pirotton, L. Haazen, G Zadoyan, Kija Shah-Hosseini
Publikováno v:
Allergy, 73 (6
Allergy
Allergy
Background: Systemic allergic reactions are a risk for allergen immunotherapy that utilizes intact allergen preparations. We evaluated the safety, efficacy and immune mechanisms of short-course treatment with adjuvant-free Lolium perenne peptides (LP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f47e9354e95645f3dfc797fb2fb82cb
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/277654
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/277654
Autor:
P. Panzner, Stephen R. Durham, Moises A. Calderon, Ralph Mösges, Mohamed H. Shamji, R. von Frenckell, Marie-Alix Bonny, L. Haazen, Oliver Pfaar, Nathalie Wathelet, Sabine Pirotton, Thierry Legon, Claus Bachert
Publikováno v:
ALLERGY
Allergy
Allergy
Background Immunotherapy with peptide hydrolysates from Lolium perenne (LPP) is an alternative treatment for seasonal allergic rhinitis with or without asthma. The aim of this study was to assess the clinical efficacy and safety of a cumulative dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::102cc6d7849fed6cb6ff2074e16a1074
https://biblio.ugent.be/publication/8582152
https://biblio.ugent.be/publication/8582152
Publikováno v:
Psychopharmacology. 118:183-187
The efficacy and tolerability of moclobemide (300-600 mg daily) and fluoxetine (20-40 mg daily) were compared in a 6-week, double-blind study of 65 inpatients and 34 outpatients suffering from major depressive episodes (DSM III-R). No statistically s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a4aa92dcd9fe481fc6434176d7541c5
https://doi.org/10.1007/bf02245838
https://doi.org/10.1007/bf02245838
Publikováno v:
British Journal of Pharmacology, Vol. 113, no. 4, p. 1113-1120 (1994)
1. As nonsteroidal anti-inflammatory drugs may impair the ability of the chondrocyte to repair its damaged extracellular matrix, we explored the changes in the metabolism of newly synthesized proteoglycan (PG) and hyaluronan (HA) molecules produced b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c955d85e9dc8fad2029154335518a88
https://doi.org/10.1111/j.1476-5381.1994.tb17111.x
https://doi.org/10.1111/j.1476-5381.1994.tb17111.x
Publikováno v:
European Neuropsychopharmacology. 21:S392-S393
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ef9b622b10591360a52dbc04e1fde72
https://doi.org/10.1016/s0924-977x(11)70631-9
https://doi.org/10.1016/s0924-977x(11)70631-9
Publikováno v:
European Neuropsychopharmacology. 21:S366-S367
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d8b3c5151f784b53351dd66924372af
https://doi.org/10.1016/s0924-977x(11)70586-7
https://doi.org/10.1016/s0924-977x(11)70586-7
Publikováno v:
European Neuropsychopharmacology. 20:S396-S397
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::051b3562b8d37f37a96c08dd0786ef6b
https://doi.org/10.1016/s0924-977x(10)70564-2
https://doi.org/10.1016/s0924-977x(10)70564-2
Publikováno v:
European journal of anaesthesiology. 14(3)
The analgesic efficacy of tenoxicam, a newer injectable non-steroidal anti-inflammatory drug, for post-operative analgesia after abdominal or orthopaedic surgery in ASA Grade I/II patients is reported. Two hundred and fifty-six patients received a si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93d6268a26fc767bdf5383640cc376de
https://pubmed.ncbi.nlm.nih.gov/9202910
https://pubmed.ncbi.nlm.nih.gov/9202910
Publikováno v:
Acta orthopaedica Belgica. 61(3)
The effect of tenoxicam 10 mg and 20 mg, administered daily for 6 weeks to prevent heterotopic bone formation after total hip arthroplasty, was evaluated in a randomized, double-blind, placebo-controlled trial involving 90 patients. After 3 months, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::27d82f32602da88262fc196fefbc40b3
https://pubmed.ncbi.nlm.nih.gov/8525817
https://pubmed.ncbi.nlm.nih.gov/8525817